AL
BMY icon

Agran Libbie’s Bristol-Myers Squibb BMY Stock Holding History

Agran Libbie’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$1.3M Sell
23,989
-1,546
-6% -$84.8K 0.31% 72
2016
Q4 		$1.49M Buy
25,535
+1,778
+7% +$97.2K 0.36% 66
2016
Q3 		$1.28M Buy
23,757
+3,242
+16% +$208K 0.37% 62
2016
Q2 		$1.51M Buy
20,515
+2,673
+15% +$189K 0.38% 68
2016
Q1 		$1.14M Buy
17,842
+12,207
+217% +$770K 0.29% 71
2015
Q4 		$388K Buy
5,635
+678
+14% +$44.8K 0.1% 96
2015
Q3 		$293K Buy
+4,957
New +$314K 0.08% 100

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Agran Libbie's BMY Position: Q1 2017 in Review

Agran Libbie reduced its Bristol-Myers Squibb (BMY) stake by 6.1% in Q1 2017, selling an estimated $84.8K and leaving 23,989 shares worth $1.3M. The position accounts for 0.31% of the portfolio, ranked #72.

Agran Libbie first reported a position in BMY in Q3 2015 and has held it in 7 quarters since. The position peaked at $1.51M in Q2 2016. 1,597 funds tracked by Wall St. Rank hold BMY as of Q1 2017.

  • Agran Libbie held 23,989 shares of Bristol-Myers Squibb worth $1.3M as of Q1 2017.
  • Agran Libbie sold 1,546 Bristol-Myers Squibb shares in Q1 2017, an estimated $84.8K.
  • Bristol-Myers Squibb made up 0.31% of Agran Libbie's portfolio in Q1 2017, its #72 holding.
  • Agran Libbie first reported a position in Bristol-Myers Squibb in Q3 2015 and has held it in 7 quarters since.
  • Agran Libbie's Bristol-Myers Squibb position peaked at $1.51M in Q2 2016.
  • 1,597 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2017.

Based on Agran Libbie's 13F filing for Q1 2017, filed 27 Apr 2017.